$PRKR
PARKERVISION INC Stock $prkr

$prkr Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000143774924034894 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$0.00
YoY Change
Cost Of Revenue		$57.00K
YoY Change		-6.56%
Gross Profit		-$57.00K
YoY Change		-6.56%
Gross Profit Margin
Selling, General & Admin		$980.0K
YoY Change		8.41%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$58.00K
YoY Change		-17.14%
% of Gross Profit
Operating Expenses		$980.0K
YoY Change		8.41%
Operating Profit		-$1.037M
YoY Change		7.46%
Interest Expense		-$94.00K
YoY Change		-187.85%
% of Operating Profit
Other Income/Expense, Net		-$9.770M
YoY Change		230.29%
Pretax Income		-$10.81M
YoY Change		175.69%
Income Tax		$0.00
% Of Pretax Income
Net Earnings		-$10.81M
YoY Change		175.48%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.12
Diluted Earnings Per Share		-$0.12
COMMON SHARES
Basic Shares Outstanding	101.1M	89.61M
Diluted Shares Outstanding		90.34M

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$821.0K
YoY Change		-75.35%
Cash & Equivalents		$800.0K
Short-Term Investments
Other Short-Term Assets		$36.00K
YoY Change		-2.7%
Inventory
Prepaid Expenses		$85.00K
Receivables
Other Receivables
Total Short-Term Assets		$942.0K
YoY Change		-72.7%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles		$889.0K
YoY Change		-21.33%
Long-Term Investments
YoY Change
Other Assets		$2.000K
YoY Change		-33.33%
Total Long-Term Assets		$891.0K
YoY Change		-21.36%
TOTAL ASSETS
Total Short-Term Assets		$942.0K
Total Long-Term Assets		$891.0K
Total Assets		$1.833M
YoY Change		-60.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$466.0K
YoY Change		-41.46%
Accrued Expenses		$752.0K
YoY Change		29.66%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$1.188M
YoY Change		0.68%
Total Short-Term Liabilities		$2.400M
YoY Change		-5.96%
LONG-TERM LIABILITIES
Long-Term Debt		$49.72M
YoY Change		316.09%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$49.72M
YoY Change		21.45%
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.400M
Total Long-Term Liabilities		$49.72M
Total Liabilities		$52.13M
YoY Change		19.85%
SHAREHOLDERS EQUITY
Retained Earnings		-$445.5M
YoY Change		2.98%
Common Stock		$964.0K
YoY Change		11.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$50.30M
YoY Change
Total Liabilities & Shareholders Equity		$1.833M
YoY Change		-60.01%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$10.81M
YoY Change		175.48%
Depreciation, Depletion And Amortization		$58.00K
YoY Change		-17.14%
Cash From Operating Activities		-$640.0K
YoY Change		-13.51%
INVESTING ACTIVITIES
Capital Expenditures		$1.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$1.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		437.0K
YoY Change		-412.14%
NET CHANGE
Cash From Operating Activities		-640.0K
Cash From Investing Activities		-1.000K
Cash From Financing Activities		437.0K
Net Change In Cash		-204.0K
YoY Change		-76.82%
FREE CASH FLOW
Cash From Operating Activities		-$640.0K
Capital Expenditures		$1.000K
Free Cash Flow		-$641.0K
YoY Change		-13.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Registrant Name EntityRegistrantName	PARKERVISION INC
	dei	Entity Central Index Key EntityCentralIndexKey	0000914139
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	96351000
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96351000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87681000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87681000
CY2024Q3	prkr	Number Of Licenses NumberOfLicenses	5	pure
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	90000.00	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-22904
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-2971472
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4446-1A Hendricks Avenue, Suite 354
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jacksonville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32207
	dei	City Area Code CityAreaCode	904
	dei	Local Phone Number LocalPhoneNumber	732-6100
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	101132954
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	821000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2560000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	85000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	61000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	36000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	942000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2655000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	889000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1055000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	313000	usd
CY2024Q3	us-gaap	Assets Assets	1833000	usd
CY2023Q4	us-gaap	Assets Assets	4023000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	466000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	573000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	54000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	101000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	67000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	597000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	447000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	138000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	134000	usd
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1050000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1045000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2406000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2289000	usd
CY2024Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39280000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	29402000	usd
CY2024Q3	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	6694000	usd
CY2023Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	7618000	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	236000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	340000	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3513000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3893000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	49723000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	41253000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	52129000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	43542000	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	964000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	877000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	394277000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	393314000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-445537000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-433710000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-50296000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-39519000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1833000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4023000	usd
CY2024Q3	us-gaap	Revenues Revenues	0	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues	25000000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	57000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	61000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	174000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	167000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-57000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-61000	usd
	us-gaap	Gross Profit GrossProfit	-174000	usd
	us-gaap	Gross Profit GrossProfit	24833000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	980000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	904000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2437000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14114000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	980000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	904000	usd
	us-gaap	Operating Expenses OperatingExpenses	2437000	usd
	us-gaap	Operating Expenses OperatingExpenses	14114000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	7000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	29000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	47000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	29000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	101000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	107000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	309000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	320000	usd
CY2024Q3	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-9676000	usd
CY2023Q3	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-2880000	usd
	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	-8954000	usd
	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	197000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9770000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2958000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9216000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-94000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-10807000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3923000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11827000	usd
	us-gaap	Net Income Loss NetIncomeLoss	10625000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10807000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3923000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11827000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10625000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90340000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86330000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89067000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85163000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90340000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86330000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89067000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119558000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-40185000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-35204000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-39519000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-50689000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-50296000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-38910000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-50296000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-38910000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11827000	usd
	us-gaap	Net Income Loss NetIncomeLoss	10625000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	176000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	195000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	226000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	408000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	8954000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-197000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	7000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-41000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	283000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	303000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-30000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-283000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	107000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-127000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	9769000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	906000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2058000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11531000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000	usd
	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	0	usd
	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	121000	usd
	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	471000	usd
	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	4000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	320000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8306000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1739000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3224000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2560000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	109000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	821000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3333000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">1.</em> Description of Business</b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">ParkerVision, Inc. (“ParkerVision”, “we” or the “Company”) is in the business of innovating fundamental wireless hardware technologies and products.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">We have designed and developed proprietary radio frequency (“RF”) technologies and integrated circuits based on those technologies, and we license those technologies to others for use in wireless communication products. We currently have <span style="-sec-ix-hidden:c120825361">five</span> licensees of our technologies. We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States of America (“U.S.”) and certain foreign jurisdictions. We believe certain patents protecting our proprietary technologies have been broadly infringed by others, and therefore the primary focus of our business plan is the enforcement of our intellectual property rights through patent licensing and infringement litigation efforts. We currently have patent enforcement actions ongoing in various U.S. district courts against mobile handset, smart television and other WiFi product providers, as well as semiconductor suppliers, for the infringement of a number of our RF patents. We have made significant investments in developing and protecting our technologies.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p>
	us-gaap	Net Income Loss NetIncomeLoss	-11800000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2100000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	800000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-445500000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2400000	usd
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1100000	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">3.</em> Basis of Presentation </b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The unaudited condensed consolidated financial statements for the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em> month periods ended <em style="font: inherit;"> September 30, 2024</em> were prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form <em style="font: inherit;">10</em>-Q and Rule <em style="font: inherit;">10</em>-<em style="font: inherit;">01</em> of Regulation S-<em style="font: inherit;">X.</em> Operating results for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024</em>, are <em style="font: inherit;">not</em> necessarily indicative of the results that <em style="font: inherit;"> may </em>be expected for the year ending <em style="font: inherit;"> December 31, 2024</em>, or future years. All normal and recurring adjustments which, in the opinion of management, are necessary for a fair statement of the consolidated financial condition and results of operations have been included.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The year-end condensed consolidated balance sheet data was derived from audited financial statements for the year ended <em style="font: inherit;"> December 31, 2023</em>. Certain information and disclosures normally included in the notes to the annual financial statements prepared in accordance with GAAP have been omitted from these interim condensed consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with our latest Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2023</em> (“<em style="font: inherit;">2023</em> Annual Report”). Certain reclassifications have been made to prior period amounts to conform to the current period presentation.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The condensed consolidated financial statements include the accounts of ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH, after elimination of all intercompany transactions and accounts. ParkerVision GmbH was dissolved and any remaining assets reverted back to the parent company as of <em style="font: inherit;"> September 30, 2024.</em></p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -18pt;"> </p>
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	25000000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-10807000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3923000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11827000	usd
	us-gaap	Net Income Loss NetIncomeLoss	10625000	usd
CY2024Q3	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	0	usd
CY2023Q3	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	0	usd
	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	0	usd
	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	302000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-10807000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3923000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-11827000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	10927000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90340000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86330000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89067000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85163000
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	34395000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90340000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86330000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89067000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119558000
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	67996000
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	72305000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	67996000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35880000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10465000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10431000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9576000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9376000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	889000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1055000	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	4563000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	4938000	usd
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1050000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1045000	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3513000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3893000	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">10.</em> Contingent Payment Obligations</b></p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Secured Contingent Payment Obligation</b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The following table provides a reconciliation of our secured contingent payment obligation, measured at estimated fair value, for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024</em> and the year ended <em style="font: inherit;"> December 31, 2023</em> (in thousands):</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 11pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><em style="font: inherit;">Nine Months Ended September 30, 2024</em></p> </td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><em style="font: inherit;">Year Ended December 31, 2023</em></p> </td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; width: 70%;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Secured contingent payment obligation, beginning of period</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">29,402</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">40,708</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 11pt; font-family: "Times New Roman";">Borrowings</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">5,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> <p style="margin: 0pt; font-size: 11pt; font-family: "Times New Roman";">Repayments</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">(13,925</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; padding: 0; margin: 0">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Change in fair value</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9,878</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(2,381</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Secured contingent payment obligation, end of period</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">39,280</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">29,402</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td></tr> </tbody></table> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">Our secured contingent payment obligation consists of a secured, non-recourse note (the "Note") and a prepaid forward purchase contract (the "PPFPA") with Brickell<span style="background-color: rgb(255, 255, 255); font-size: 11pt;"> Key Investments, LP (“Brickell”). </span> The Note has a face value of $45.5 million ("Face Value"), accrues simple interest at a fixed rate, and matures on <em style="font: inherit;"> August 14, 2028. </em>Payments under the Note will be made solely from proceeds from our patent assets, net of contingent fees payable to attorneys ("Distributions"). We are obligated to pay <em style="font: inherit;">one hundred</em> percent (100%) of the <em style="font: inherit;">first</em> $5.8 million in Distributions to Brickell, and thereafter will pay a percentage of Distributions, which varies depending upon the origin of the Distributions, until the Face Value of the Note, and accrued interest thereon, has been repaid in full. If the amounts payable to Brickell from Distributions are insufficient to repay the face value and interest accrued on the Note by the maturity date, our remaining repayment obligations under the Note will be reduced to <em style="font: inherit;">zero</em> with future payment obligations, if any, being determined under the PPFPA. The Note is secured by our patent assets and related proceeds and contains standard and customary representations, warranties and covenants. The Note contains events of default including, but <em style="font: inherit;">not</em> limited to, (a) failure to pay principal or interest on the Note when due; (b) breach of representations or covenants, (c) impairment in the perfection or priority of Brickell's security interests in the collateral, and (d) bankruptcy or dissolution of the Company. In the event of a default, the outstanding principal and accrued interest on the Note will become immediately due and payable. The PPFPA extends beyond the maturity date of the Note and provides that Brickell is entitled to a specified percentage of monetary recoveries resulting from our patent-related actions to the extent <em style="font: inherit;">not</em> already paid to Brickell under the Note, or otherwise prior to the inception of the Note. The PPFPA also contains standard and customary representations, warranties and covenants. The Note and PPFPA are collectively referred to as our secured contingent payment obligation.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">We have elected to measure our secured contingent payment obligation at its estimated fair value based on probability-weighted estimated cash outflows, discounted back to present value using a discount rate determined in accordance with accepted valuation methods (see Note <em style="font: inherit;">11</em>). The secured contingent payment obligation is remeasured to fair value at each reporting period with changes recorded in the condensed consolidated statements of comprehensive income (loss) until the contingency is resolved.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The underlying carrying value of the Note, which includes the Face Value plus accrued interest, was approximately $57.1 million and $51.0 million as of <em style="font: inherit;"> September 30, 2024</em> and <em style="font: inherit;"> December 31, 2023</em>, respectively. The range of potential proceeds payable to Brickell is discussed more fully in Note <em style="font: inherit;">11.</em> As of <em style="font: inherit;"> September 30, 2024</em>, we are in compliance with our obligations under the Note and the PPFPA.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Unsecured Contingent Payment Obligations</b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The following table provides a reconciliation of our unsecured contingent payment obligations, measured at estimated fair value, for the <em class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024</em> and the year ended <em style="font: inherit;"> December 31, 2023</em> (in thousands):</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 11pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">Nine Months Ended September 30, 2024</em></td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 11pt;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">Year Ended December 31, 2023</em></td><td style="font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt; width: 70%;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Unsecured contingent payment obligations, beginning of period</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">7,618</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;">5,089</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Change in fair value</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(924</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,529</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: Times New Roman; font-size: 11pt;"> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;">Unsecured contingent payment obligations, end of period</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,694</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 11pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7,618</td><td style="width: 1%; font-family: Times New Roman; font-size: 11pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td></tr> </tbody></table> <hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">Our unsecured contingent payment obligations represent amounts payable to others from future patent-related proceeds including (i) a termination fee due to a litigation funder and (ii) contingent payment rights issued to accredited investors in connection with equity financings. We have elected to measure these unsecured contingent payment obligations at their estimated fair value based on probability-weighted estimated cash outflows, discounted back to present value using a discount rate determined in accordance with accepted valuation methods. The unsecured contingent payment obligations will be remeasured to fair value at each reporting period with changes recorded in the condensed consolidated statements of comprehensive loss until the contingency is resolved (see Note <em style="font: inherit;">11</em>).</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p>
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	120000
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000.00	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	250000
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000.00	usd
CY2024Q3	prkr	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	2600000
CY2024Q3	prkr	Class Of Warrant Or Right Exercised In Period Exercise Price ClassOfWarrantOrRightExercisedInPeriodExercisePrice	0.16
CY2024Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	400000	usd
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7700000
	prkr	Class Of Warrant Or Right Weighted Average Remaining Life ClassOfWarrantOrRightWeightedAverageRemainingLife	P0Y9M18D
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	80000.00	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	130000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y8M12D
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure

Files In Submission

Name	View Source	Status
0001437749-24-034894-index-headers.html	Edgar Link	pending
0001437749-24-034894-index.html	Edgar Link	pending
0001437749-24-034894.txt	Edgar Link	pending
0001437749-24-034894-xbrl.zip	Edgar Link	pending
ex_722807.htm	Edgar Link	pending
ex_722808.htm	Edgar Link	pending
ex_722809.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prkr-20240930.xsd	Edgar Link	pending
prkr20240930c_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
prkr-20240930_cal.xml	Edgar Link	unprocessable
prkr-20240930_def.xml	Edgar Link	unprocessable
prkr-20240930_lab.xml	Edgar Link	unprocessable
prkr-20240930_pre.xml	Edgar Link	unprocessable
prkr20240930c_10q_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRKR
PARKERVISION INC Stock $prkr

2024 Q4 Form 10-Q Financial Statement

#000143774924034894 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR PARKERVISION INC Stock $prkr

2024 Q4 Form 10-Q Financial Statement

#000143774924034894 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR
PARKERVISION INC Stock $prkr